For business leaders, corporate strategists, and growth-focused teams – this report delivers deep market intelligence, forecasts, segmentation, and competitor insights to guide your decisions through 2034.
What is the forecasted revenue size of the veterinary cardiology industry by 2029?
The veterinary cardiology market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing pet ownership, growing awareness of pet health, rising prevalence of cardiac disorders in animals, expansion of veterinary specialty clinics, and the increasing availability and affordability of pet insurance.
The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing investment in veterinary cardiology research, expansion of telemedicine services for remote consultations, growth in pet adoption rates, rising consumer demand for specialized veterinary care, and the increasing availability of advanced veterinary cardiology training programs. Major trends in the forecast period include cloud security solutions, integrated collaboration platforms, enhanced focus on data privacy and compliance, accelerated migration to multi-cloud environments, and the development of more scalable and flexible cloud infrastructure solutions.
Download Your Free Sample PDF:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20681&type=smp
Which industry-specific innovations are acting as key drivers for the veterinary cardiology market?
The rising cases of heart diseases in pets and livestock are expected to propel the growth of the veterinary cardiology market going forward. Heart diseases in pets and livestock refer to medical conditions that affect the heart’s structure and function, leading to impaired blood circulation, reduced cardiac efficiency, and potential complications in overall health. The rising cases of heart diseases in pets and livestock are driven by factors such as increased lifespan, obesity, poor diet, genetic predispositions, and a lack of regular veterinary care. Additionally, environmental stressors and changes in living conditions can contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology helps diagnose, treat, and manage heart diseases in pets and livestock through specialized care, advanced imaging, and innovative procedures like minimally invasive surgeries to improve heart health and quality of life. For instance, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, Myxomatous mitral valve degeneration (MMVD) is the most prevalent heart disease in dogs in North America, making up 75% of all canine cardiac conditions. It is reported that 85% of small dogs aged 13 years show signs of a myxomatous mitral valve lesion, although the presence of a lesion does not necessarily have clinical significance. In cases of MMVD, the estimated rate of cardiac-related deaths in dogs is between 40% and 70%. Therefore, the rising cases of heart diseases in pets and livestock will drive the growth of the veterinary cardiology market.
Which segment currently leads the veterinary cardiology market in terms of revenue share?
The veterinary cardiology market covered in this report is segmented –
1) By Product: Pharmaceuticals, Diagnostics
2) By Indication: Congestive Heart Failure, Myocardial (Heart Muscle) Disease, Arrhythmias, Other Indications
3) By Animal Type: Companion Animals, Production Animals
4) By End-User: Veterinary Hospitals, Clinics, Other End Users
Subsegments:
1) By Pharmaceuticals: Antihypertensives, Diuretics, Antiarrhythmic Drugs, Beta Blockers, ACE Inhibitors, Calcium Channel Blockers, Positive Inotropes, Nutraceuticals For Cardiac Health
2) By Diagnostics: Electrocardiograms (ECG), Echocardiography Devices, Holter Monitors, Blood Pressure Monitors, Cardiac Biomarker Tests, Thoracic Radiography, Ultrasound Devices, Telemedicine Solutions for Cardiac Monitoring
View The Full Market Report:
https://www.thebusinessresearchcompany.com/report/veterinary-cardiology-global-market-report
What future trends will impact the direction of the veterinary cardiology industry?
Major companies operating in the veterinary cardiology market are developing technological advancements, such as transcatheter edge-to-edge mitral valve repair (TEER), to improve the treatment of heart diseases in animals, enhance surgical outcomes, and offer minimally invasive alternatives for better patient recovery and quality of life. Transcatheter edge-to-edge mitral valve repair (TEER) is a less invasive heart procedure designed to fix mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral center, launched a groundbreaking heart treatment for dogs to treat myxomatous mitral valve disease (MMVD), which is the most common heart condition in dogs. It is now regarded as a viable alternative to surgical repair in human patients, with early clinical results in dogs showing great promise. The procedure is conducted under general anesthesia through a minor incision in the chest wall. A needle is inserted at the heart’s apex, with precise guidance provided by continuous X-rays and transesophageal ultrasound. This method facilitates the accurate placement of a V-clamp across the mitral valve to minimize leakage.
Who are the top competitors in the global veterinary cardiology market?
Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet
What regional dynamics are shaping the future of the global veterinary cardiology market?
North America was the largest region in the veterinary cardiology market in 2024. The regions covered in the veterinary cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Can Companies Use The Veterinary Cardiology Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.
Purchase The Report And Get A Swift Delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20681
Need Customized Data On Veterinary Cardiology Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you’re entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.
Request Customized Data:
https://www.thebusinessresearchcompany.com/customise?id=20681&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
